Introduction
In 2002, the National Treatment Agency for Substance Misuse (NTA) published its 'Models of Care' document which described the range of services that should be available in every drug action team (DAT) area in England. The Models of Care document advocates primary care based treatment services for drug misusers and mentions community pharmacy based services such as needle exchange and supervised methadone consumption but does not discuss the standards by which these services should be provided. This research aims to inform a community pharmacy 'Model of Care' and is part of a larger project employing both quantitative and qualitative methods. The study reported here was preceded by a large postal questionnaire which was sent to 903 community pharmacies in the South West of England. On the basis of the questionnaire findings, qualitative interviews were then undertaken to further explore the key factors identified in the questionnaire. In order to propose a new 'Model of Care' it is important to understand what would facilitate the models use and what may inhibit community pharmacists from using it.
To examine whether the prescription charge status of a patient influences enrolment in RD and the duration of the medication prescribed.

Method
This was a semi-structured interview study that was designed to understand the experiences of community pharmacists who provide drug misuse services. Approval was gained from the Central and South Bristol Research Ethics Committee before commencement of the study. Community pharmacists were recruited as a result of their indication of willingness to participate in further research in their replies to the preceding postal questionnaire. Thirty one interviews were carried out between September 2004 and January 2005. All were transcribed verbatim and read. The first 20 transcripts were included in the final analysis as no new themes or points for discussion was found in the remaining transcripts. Analysis was carried out using the software program 'NVivo' and themes were generated using Interpretative Phenominological Analysis (IPA).

Results
Nine major themes were identified from the analysis of the interview transcripts. One of these themes was named 'Perceived facilitators and barriers to a Pharmacy Model of Care' and this abstract focuses on this theme. Participants felt that training, teamwork and the new pharmacy contract would help facilitate a Model of Care whilst identifying that the attitude of pharmacists and their staff towards drug misusers, the perceived effect of drug misusers on the pharmacy business, a lack of training and wider understanding of drug misuse, a lack of understanding of the pharmacists' role in caring for drug misusers by other healthcare professionals and a lack of two-way information sharing between prescriber/ key worker and pharmacists were potential barriers to the successful implementation of a Model of Care.

Conclusion
This qualitative study has provided some important considerations for the proposal and implementation of a Model of Care for community pharmacy services to drug misusers. One important facilitator is training, as a lack of training was also identified as a potential barrier. The Model of Care should therefore contain a list of training needs for pharmacists who provide drug misuse services. The other barriers must be considered and ways of limiting their impact on the implementation of the Model of Care will be considered in future work.